| Bax, human Bax Elisa, (Bcl1 associated x protein) | EIA4487 | IFU | 60 /60/30/30 min | 62.5 - 2,000 pg/mL // 10.1 pg/mL | 10 uL total cell lysates | quantitative | MTPL | 96 wells |
| Bcl-2, human Bcl-2 Elisa (B-cell lymphoma 2) | EIA4488 | IFU | 60/60/30/30 min | 18.8 - 1,200 pg/mL // 3.8 pg/mL | 100 uL total cell lysates | quantitative | MTPL | 96 wells |
| CA 125 | EIA3939 | | 50 / 30 min | 15 - 200 U/ml // 3.327 U/ml | 50 ul serum, plasma | quantitative | MTPL | 96 wells |
| CA 125 Irma | RIA4438 | IFU | 120 / 60 min | 4,8 - 786 U/ml // 0,7 U/ml | 100 uL serum | CT | I125 | 48 tests |
| CA 125 (Ovarian Cancer) Antigen | EIA1472 | IFU | 3 hrs. at 37 C. | 5 U/ml | serum | quantitative | MTPL | 96 wells |
| CA 125 II | RIA3933 | IFU | 20h (RT) | 15-500 U/ml / 0.4 U/ml | 100 ul serum | CT Beads | I125 | 100 tests |
| CA 15-3 | EIA3941 | | 60/30/30 min | 25-200 U/ml // 0.905 U/ml | 10 ul serum, plasma | quantitative | MTPL | 96 wells |
| CA 15-3 | RIA3935 | IFU | 2h RT/3h RT | 25-200 U/ml / 1.4 U/ml | 20 ul serum, plasma | CT Beads | I125 | 100 tests |
| CA 15-3 (Breast Cancer) Antigen (BCA) | EIA1473 | IFU | 120 min. at 37 C. | 5 U/ml | serum | quantitative | MTPL | 96 wells |
